by Dan Roberts Updated April 2014 A new finding by researchers at Trinity College Dublin may lead to another treatment for wet AMD. Inflammation in the retina results from blood vessel development, and the natural component named IL-18 has been found to keep the process under control. By injecting the chemical into the eye, or [Read More]
Category: Research and Developments
What Is Macular Degeneration?
by Dan Roberts (Updated 9/12/2023) Audio/visual presentations on all related subjects Recommended books: The First Year: Age-Related Macular Degeneration: An Essential Guide for the Newly Diagnosed by Daniel L. Roberts Macular Degeneration: The Complete Guide to Saving and Maximizing Your Sight by Lylas Mogk, M.D. and Marja Mogk, Ph.D. Definition Age-related macular degeneration (AMD) is [Read More]
New Radiation Treatment for Wet AMD
by Dan Roberts [It was reported on 2/9/12 that Phase III of this study did not meet it’s primary endpoint at 2 years. The information in this article describes the progress up to that point.] NeoVista, Inc. announced on June 17, 2007 the official commencement of the CABERNET (Cnv secondary to Amd treated with BEta [Read More]
New Treatment for Dry AMD Using HuCNS Stem Cells
by Dan Roberts February 2, 2012 StemCells, Inc. announced on February 2, 2012 that the FDA has authorized a Phase I/II clinical trial of a new method using stem cells from the brain to prevent degeneration of the macula in dry AMD patients. Purified human neural stem cells (HuCNS-SC) will be administered by a single [Read More]
Encapsulated Cell Technology (ECT)–A New Drug Delivery System
by Dan Roberts Updated March 30, 2015 A means of delivering drugs into the retina on a time release basis is being developed and proven safe and effective. It is achieved by a method called Encapsulated Cell Technology (ECT), being tested by Neurotech SA with support from the National Eye Institute (NEI), Bethesda, Maryland. A [Read More]